174 related articles for article (PubMed ID: 8202031)
1. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.
Gadner H; Grois N; Arico M; Broadbent V; Ceci A; Jakobson A; Komp D; Michaelis J; Nicholson S; Pötschger U; Pritchard J; Ladisch S;
J Pediatr; 2001 May; 138(5):728-34. PubMed ID: 11343051
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Langerhans cell histiocytosis--evolution and current approaches.
Ladisch S; Gadner H
Br J Cancer Suppl; 1994 Sep; 23():S41-6. PubMed ID: 8075005
[TBL] [Abstract][Full Text] [Related]
4. Acute leukemia in association with Langerhans cell histiocytosis.
Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME
Med Pediatr Oncol; 1994; 23(2):81-5. PubMed ID: 8202046
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide.
Yu LC; Shenoy S; Ward K; Warrier RP
Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):275-7. PubMed ID: 8037350
[TBL] [Abstract][Full Text] [Related]
6. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S
Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489
[TBL] [Abstract][Full Text] [Related]
7. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
[TBL] [Abstract][Full Text] [Related]
8. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X).
Viana MB; Oliveira BM; Silva CM; Rios Leite VH
Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis.
Haupt R; Fears TR; Rosso P; Colella R; Loiacono G; de Terlizzi M; Mancini A; Comelli A; Indolfi P; Donfrancesco A
Pediatr Hematol Oncol; 1994; 11(5):499-507. PubMed ID: 7826846
[TBL] [Abstract][Full Text] [Related]
10. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.
Gadner H; Heitger A; Grois N; Gatterer-Menz I; Ladisch S
Med Pediatr Oncol; 1994; 23(2):72-80. PubMed ID: 8202045
[TBL] [Abstract][Full Text] [Related]
11. Langerhans-cell histiocytosis--excellent response to etoposide.
Mayou SC; Chu AC; Munro DD; Plowman N
Clin Exp Dermatol; 1991 Jul; 16(4):292-4. PubMed ID: 1794174
[TBL] [Abstract][Full Text] [Related]
12. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X).
Broadbent V; Pritchard J; Yeomans E
Med Pediatr Oncol; 1989; 17(2):97-100. PubMed ID: 2784842
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cell histiocytosis and acute leukemia: unusual association in two cases.
Aricò M; Comelli A; Bossi G; Raiteri E; Piombo M; Egeler RM
Med Pediatr Oncol; 1993; 21(4):271-3. PubMed ID: 8469222
[TBL] [Abstract][Full Text] [Related]
14. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.
Minkov M
Paediatr Drugs; 2011 Apr; 13(2):75-86. PubMed ID: 21351807
[TBL] [Abstract][Full Text] [Related]
15. Treatment of adult Langerhans cell histiocytosis with etoposide.
Tsele E; Thomas DM; Chu AC
J Am Acad Dermatol; 1992 Jul; 27(1):61-4. PubMed ID: 1619078
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis.
Matsuzaki A; Inamitsu T; Watanabe T; Ohga S; Ishii E; Nagotoshi Y; Tasaka H; Suda M; Ueda K
Br J Haematol; 1994 Apr; 86(4):887-9. PubMed ID: 7918090
[TBL] [Abstract][Full Text] [Related]
17. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
[TBL] [Abstract][Full Text] [Related]
18. Treatment for multisystem Langerhans' cell histiocytosis.
Katz BZ
J Pediatr; 2002 Feb; 140(2):280. PubMed ID: 11865293
[No Abstract] [Full Text] [Related]
19. Serum levels of interleukin-1 receptor antagonist and tumor necrosis factor-alpha are elevated in children with Langerhans cell histiocytosis.
Rosso DA; Ripoli MF; Roy A; Diez RA; Zelazko ME; Braier JL
J Pediatr Hematol Oncol; 2003 Jun; 25(6):480-3. PubMed ID: 12794527
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Langerhans cell histiocytosis in children with etoposide.
Ishii E; Matsuzaki A; Okamura J; Inoue T; Kajiwara M; Uozumi T; Yoshida N; Miyazaki S; Miyake K; Matsumoto T
Am J Clin Oncol; 1992 Dec; 15(6):515-7. PubMed ID: 1449115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
